⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006247 | 0.71 | — | — | |
| SCHEMBL4926718 | 0.71 | — | — | |
| SCHEMBL533497 | 0.71 | — | — | |
| SCHEMBL467077 | 0.68 | — | — | |
| SCHEMBL1199660 | 0.67 | — | — | |
| SCHEMBL1476980 | 0.67 | HPGD (0.34) | — | |
| SCHEMBL1477525 | 0.67 | — | — | |
| SCHEMBL7588160 | 0.67 | — | — | |
| SCHEMBL3959069 | 0.67 | — | — | |
| SCHEMBL17103337 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3474845-B1 | IMMUNOMODULATOR COMPOUNDS | CHEMOCENTRYX INC (US) | 2024-03-20 | — | — | EP | claimed |
| EP-3664793-B1 | MACROCYCLIC IMMUNOMODULATORS | CHEMOCENTRYX INC (US) | 2022-06-29 | — | — | EP | claimed |
| CN-112752755-A | Heterocyclyl compounds for the treatment of autoimmune diseases | 豪夫迈·罗氏有限公司 | 2021-05-04 | — | — | CN | claimed |
| EP-3664793-A1 | MACROCYCLIC IMMUNOMODULATORS | ChemoCentryx, Inc. (US) | 2020-06-17 | — | — | EP | claimed |
| EP-3474845-A1 | IMMUNOMODULATOR COMPOUNDS | ChemoCentryx, Inc. (US) | 2019-05-01 | — | — | EP | claimed |
| US-20190048022-A1 | MACROCYCLIC IMMUNOMODULATORS | CHEMOCENTRYX, INC. | 2019-02-14 | — | — | US | claimed |
| WO-2019032547-A1 | MACROCYCLIC IMMUNOMODULATORS | CHEMOCENTRYX, INC. (US) | 2019-02-14 | — | — | WO | claimed |
| US-20180008554-A1 | IMMUNOMODULATOR COMPOUNDS | CHEMOCENTRYX, INC. | 2018-01-11 | — | — | US | claimed |
| WO-2018005374-A1 | IMMUNOMODULATOR COMPOUNDS | CHEMOCENTRYX, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| EP-2651930-B1 | BIARYLAMIDE INHIBITORS OF LEUKOTRIENE PRODUCTION | BOEHRINGER INGELHEIM INT (DE) | 2015-10-28 | — | — | EP | claimed |
| US-20090048256-A1 | Pyrazole Compounds Having Cannabinoid Receptor (CB1) Antagonizing Activity | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-02-19 | — | — | US | claimed |
| EP-1951678-A1 | PYRAZOLE COMPOUNDS HAVING CANNABINOID RECEPTOR (CB1) ANTAGONIZING ACTIVITY | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-08-06 | — | — | EP | claimed |
| WO-2008065068-A2 | SUBSTITUTED DIHYDROIMIDAZOLES AND THEIR USE IN THE TREATMENT OF TUMORS | NOVARTIS AG (CH) | 2008-06-05 | — | — | WO | claimed |
| WO-2007046550-A1 | PYRAZOLE COMPOUNDS HAVING CANNABINOID RECEPTOR (CB1) ANTAGONIZING ACTIVITY | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-04-26 | — | — | WO | claimed |
| US-6969728-B2 | Antiinflammatory agents | GENZYME CORPORATION (US) | 2005-11-29 | — | — | US | claimed |
| US-6576628-B1 | Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis | ROCHE DIAGNOSTICS GMBH (DE) | 2003-06-10 | — | — | US | claimed |
| US-4843078-A | ANXIOLYTIC AGENTS | SUMITONO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1989-06-27 | — | — | US | claimed |
| EP-0014322-B1 | POLYCARBONATE COMPOSITION CONTAINING A METAL SALT OF AN AROMATIC SULFONAMIDE AS AN IGNITION DEPRESSANT | THE DOW CHEMICAL COMPANY (US) | 1983-01-12 | — | — | EP | claimed |
| US-4254015-A | Polycarbonate containing an aromatic sulfonamide as an ignition depressant | THE DOW CHEMICAL COMPANY (US) | 1981-03-03 | — | — | US | claimed |
| EP-0014322-A1 | Polycarbonate composition containing a metal salt of an aromatic sulfonamide as an ignition depressant | THE DOW CHEMICAL COMPANY (US) | 1980-08-20 | — | — | EP | claimed |